Great discussions during the presentations at the Complement-based drug development summit. Dr. Michael Schwenkert shares insights on performing robust quantitative evaluation of biomarkers, functional detection of anaphylatoxins, and functional assessment of individual pathways- and convertase activity. #ComplementSummit #Complementbiology #ComplementingLifeScience #ComplementTherapeutics
USA Executive Director of Business Development @ Svar Life Science AB (formerly Euro Diagnostica AB)
1yGreat job 👏